Method Article

Assessing the Palmitoylation State of Cell Membrane Proteins from Mouse Brain Tissue

July 8th, 2025

In This Article

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Source: Speca, D. J., et al. Acyl-PEGyl Exchange Gel Shift Assay for Quantitative Determination of Palmitoylation of Brain Membrane Proteins. J. Vis. Exp. (2020).

The video demonstrates the analysis of the palmitoylation state of cell membrane proteins isolated from mouse brain tissue. The process involves exposing the non-palmitoylated cysteines and blocking them, then using a polymer that binds to the palmitoylated cysteines, aiding in assessing the palmitoylation state of the isolated proteins.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All procedures involving animal samples have been reviewed and approved by the appropriate animal ethical review committee.  

1. Preparation of mouse brain membranes

  1. Decapitate mouse using a guillotine apparatus and dissect brain out rapidly (in <1 min, if possible, to minimize palmitoylation changes that may occur during dissection procedure). Homogenize immediately in 10 mL of homogenization buffer (Table 1) in a glass homogenizer (~12 strokes) on ice.
  2. Centrifuge lysates for 15 min at 1,400 x g at 4 °C. Transfer the supernatant to a new tube on ice. Resuspend the pellet (~6 strokes) in an equal volume of homogenization buffer and centrifuge at 710 x g for 10 min at 4 °C.
  3. Combine the supernatants from step 1.2 and centrifuge at 40,000 x g for 20 min at 4 °C.
  4. Discard the supernatant (cytosolic fraction) and resuspend the pelleted membrane (P2) fraction in homogenization buffer.
    NOTE: Samples can be flash frozen and stored at -80 °C for later use.
  5. Perform a bicinchoninic acid (BCA) assay to quantitate protein levels. For the Acyl-PEGyl exchange gel-shift (APEGS) assay, begin with ~100−200 mg protein (maximum 250 mg) in a volume of 470 µL of buffer A (Table 1) in a 1.5 mL tube. Sonicate and centrifuge at >13,000 x g for 10 min at 25 °C to remove insoluble protein. Transfer solubilized protein to a new 1.5 mL tube.

2. Acyl-PEGyl exchange gel-shift (APEGS) assay

  1. Disrupt disulfide bonds and block free cysteines.
    1. Disrupt disulfide bonds by incubating in 25 mM tris(2-carboxyethyl)phosphine (TCEP; 25 µL, added from a stock solution; Table 1) for 60 min at 55 °C.
    2. Block free cysteines with 50 mM N-ethylmaleimide (NEM; 12.5 µL, added from a stock solution; Table 1) at room temperature for 3 h.
      NOTE: The reaction can be extended overnight.
  2. Perform chloroform methanol (CM) precipitation.
    1. Transfer the protein solution from 1.5 mL tube to a polypropylene or glass tube that can be centrifuged in a swinging bucket rotor at modest speed. A 5 mL tube is ideal. Add four volumes (2 mL) of methanol (MeOH) and vortex briefly.
    2. Add two volumes (1 mL) of chloroform and vortex briefly.
    3. Add three volumes (1.5 mL) of deionized water (dH2O) and vortex briefly.
    4. Centrifuge the samples at 3,000 x g for 30 min at 25 °C in a swinging bucket rotor.
    5. Carefully remove and discard the upper phase.
    6. Add 3 volumes (1.5 mL) of MeOH and mix gently but thoroughly, being careful not to fragment the opaque protein pancake.
    7. Centrifuge at 3,000 x g for 10 min at 25 °C in a swinging bucket rotor.
    8. Using a glass serological pipet, remove as much of the top phase as possible without disturbing the protein pancake.
    9. Carefully rinse the pellet with 1 mL of MeOH.
    10. Air dry the pellet for at least 10 min.
      NOTE: Dried pellet can be stored at -20 °C.
  3. Perform cleavage of palmitoyl-thioester linkages with hydroxylamine (NH2OH, HAM).
    1. Resuspend the protein precipitate in 125 µL of buffer A and sonicate briefly. Centrifuge at >13,000 x g for 10 min at 25 °C to remove insoluble material. Transfer solubilized protein to a new 1.5 mL tube.
    2. Add 375 µL of buffer H (HAM+; Table 1) or buffer T (HAM-; Table 1) and incubate samples for 60 min at 25 °C.
  4. Repeat the CM precipitation described in step 2.2.
    NOTE: Dried pellet can be stored at -20 °C.
  5. Add mPEG to unprotected cysteines.
    1. Resuspend pellet in 100 µL of buffer A containing 10 mM TCEP. Transfer to a 1.5 mL tube.
      NOTE: It is normal for significant loss of protein to have occurred during CM precipitation steps. All subsequent steps will be performed in a 1.5 mL tube, constraining the volume of protein to a maximum of ~120−130 µL. This will reduce protein loss during the final CM precipitation.
    2. Add 20 mM mPEG-5k (25 µL, added from a stock solution; Table 1) to protein sample and mix by pipetting. Incubate for 60 min at 25 °C with end-over-end rotation.
    3. To remove unincorporated mPEG-5k, perform CM precipitation as described in step 2.2 using these adjusted volumes: 4 volumes of MeOH (500 µL), 2 volumes of chloroform (250 µL), and 3 volumes of dH2O (375 µL). Centrifuge at >13,000 x g for 10 min at 25 °C.
    4. Carefully remove the upper phase as before, avoiding the thick, flocculent pancake. Add 1 mL of MeOH and mix gently but thoroughly. Centrifuge at >13,000 x g for 10 min at 25 °C.
    5. Carefully remove the supernatant and rinse the pellet with 1 mL of MeOH. Centrifuge at >13,000 x g for 10 min at 25 °C. Air dry pellet.
      NOTE: Dried pellet can be stored at -20 °C.
    6. Resuspend the dried pellet in 50 µL of buffer A (without TCEP or any reducing agent).

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Table 1: Solutions used for APEGS assay. Homogenization buffer and buffer A can be prepared ahead of time; however, add protease inhibitors and phenylmethylsulfonyl fluoride (PMSF) immediately before use. All other solutions should be prepared fresh.

BufferComponentsWorking conc.

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
No conflicts of interest declared.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Hydroxylamine (HAM) ThermoFisher 26103
Methoxy-PEG-(CH2)3NHCO(CH2)2-MAL (mPEG)NOFME-050MAMW ~5000 kDa
MicrofugeEppendorf5415Ror equivalent equipment
N-ethylmalemide (NEM)Calbiochem34115Highly toxic
Optical imager for densitometryAzure BiosystemsSapphire Biomolecular Imageror equivalent equipment
Polypropylene tubes with capFisher Scientific14-956-1D
Serological pipets (glass)Fisher Scientific13-678-27D
Table top centrifugeBeckmanAllegra X-15Ror equivalent equipment
Tris(2-carboxyethyl)phosphinehydrochloride (TCEP)EMD Millipore580560

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Chloroform Methanol PrecipitationCysteine ModificationPolymer Binding AssayProtein IsolationThioester CleavagePost Translational ModificationBiochemical Analysis

Related Articles